Evidence grade: WEAK — Supported only by weak or preliminary evidence.
computed from the encoded evidence by the Atlas grading rule.
Chemical-shift signal drop and ADC thresholds separate benign from malignant marrow with good performance
Thresholds vary across sites/vendors, acute benign fractures overlap with malignant, and no universal ADC cutoff holds
Determines staging and biopsy; misread drives unnecessary biopsy or missed metastasis.
This is an educational research resource from Resonant Labs, not clinical advice. Evidence grades and controversies are summarized from the literature and may change as the field evolves.